Clin Osteol 2008; 13(2): 71-75

Osteomalacia as the first sign of Sjogren's syndromeNews

H. Ciferská, P. Horák, M. Skácelová, A. Smržová, J. Zadražil

At the department of rheumatology, a 44-year-old female was examined with a long history of musculoskeletal pain and significant loss of bone mineral density. The laboratory findings showed higher levels of the bone fraction of alkaline phosphatase and normal calci­ um levels. Bone histomorphometry revealed the presence of osteomalacia. Subsequently, the patient was found to have renal tubular acidosis, increased renal bicarbonate loss, glycosuria and aminoaciduria. Some time later, the diagnosis of primary Sjogren's syndro­ me (SS) was made, with fully manifested clinical and immunological findings. Secondary osteomalacia diagnosed in the patient was a rare manifestation of Fanconi syndrome. The syndrome is a less common manifestation of SS but occasionally it precedes the typi­ cal glandular manifestation of SS. Sjogren's syndrome is an autoimmune disease, mostly affecting exocrine glands and often associa­ ted with other autoimmune diseases. Its manifestations vary in severity, from isolated sicca syndrome to severe systemic manifestations in the form of vasculitis and pulmonary and renal involvement. Renal tubular acidosis, either latent or manifested, caused by auto­ immune tubulointerstitial nephritis is one of the less frequent extraglandular manifestations of the disease. In Sjogren's syndrome pa­ tients, this manifestation should be considered to prevent development of

Keywords: Fanconi syndrome, Sjogren's syndrome, osteomalacia, osteoporosis

Published: December 11, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ciferská H, Horák P, Skácelová M, Smržová A, Zadražil J. Osteomalacia as the first sign of Sjogren's syndrome. Osteologický bulletin. 2008;13(2):71-75.
Download citation

References

  1. Pavelka K. a kolektiv autorů Farma tických onemocnění. Grada 2005;291-3.
  2. Pillemer SR, Matteson EL, Jacobson LT et al. In dence of physician diagnose primary Sjogren's syn­ drome in residents of Olmsted Country, Minnesota. Myao Clin Proc. 2001;76:593-6. Go to original source...
  3. Vitali C, Bombardiere S, Jonsson R et al. Classifi tion criteria for Sjogren's syndrome:A revised versi­ on of the European criteria proposed by the Ameri­ can-European Consensus Group. Ann Rheum 2002;61:554-8. Go to original source...
  4. Pavelka K, Rovenský J et al.K linická revmatologie Galén 2003;303-9.
  5. Tengner P, Halse AK, Haga HJ et al. Detection of anti-Ro/SSA and anti-LA/SSB autoantibody-produ­ cing cells in salivary glans of patients with Sjogre­ n's syndrome. Arthtitis Rheum 1998;41:2238-48. Go to original source...
  6. Talal N Recent developments in the immunology of Sjogren's syndrome. Scand J Rheum 1986;61:76-82.
  7. Haga HJ, Hulten B, Bolstad AL et.al. Reliability and sensitivity ofthe diagnostic tests f n's syndrome. J Rheum 1999;26:604-8.
  8. Zulman J.,Jaffe R., Tatal N.: Evidence that lignit lamyphoma of Sjogren's syndrome is a mo­ noclonal B-cell neoplasm. New Eng. Med. 1978;299: 1215-1220. Go to original source...
  9. Janin A, Morel P., Quiquandon I., et al: Nonkin's lymphoma and Sjogren's syndrome: An immunopathological study of 113 patients. Clin. Exp. Rheum. 1992;10:565-570.
  10. Skopouli F.N. Dafni U., loannidis J.P. et al.: Clin evolution and morbidity and mortality in primary Sjogren's syndrome. Arthritis Rheum. 2000;29: 296-304. Go to original source...
  11. Mavragani CP, Moutsopoulos NM, Moutsopoulos HM The management of Sjogren's syndrome. Nat Clin Pract Rheumatol 2006;2:252-61. Go to original source...
  12. Drosos AA, Skopuli FN, Costopoulos JS et al. Cyc­ losporin A (CyA) in primary Sjogren's syndrome: double blind study. Ann Rheum Dis 1986;45:732-5. Go to original source...
  13. Bagga A, Sinha A Evaluation of renal tubular acido­ sis. Indian J Pediatr 2007;74:679-86. Go to original source...
  14. Comer DM, Droogan AG, Young IS Hypokalaemic paralysis precipitated by distal renal tubular acidosis secondary to Sjogren's syndrome. Ann Clin Biochem 2008;45:221-5. Go to original source...
  15. Kawashima M, Amano T, Morita Y et al. Hypokale­ mic paralysis and osteomalacia secondary to renal tubular acidosis in a case with primary Sjogren's syndrome. Mod Rheumatol 2006;16:48-51. Go to original source...
  16. Barbier O, Jacquillet G, Tauc M et al. Effect vy metals on, and handling by, the kidney. Nephron Physiol 2005;99:105-10. Go to original source...
  17. Teplan V et al. Praktická nefrologie. cované a doplněné vydání Grada. 2006;314.
  18. Kobayashi T, Muto S, Nemoto J et al. Fanconi's drome and distal (type 1) renal tubular acidosis in a patient with primary Sjogren's syndrome with mo­ noclonal gammopathy of undetermined significance. Clin Nephrol 2006;65:427-32. Go to original source...
  19. Yang YS, Peng CH, Sia SK et al. Acquired hypop­ hosphatemia osteomalacia associated with Fanconi­ 's syndrome in Sjogren's syndrome. Rheumatol Int 2007;27:593-7. Go to original source...




Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.